DR. SETH J. BAUM, MD
Osteopathic Medicine at Glades Rd, Boca Raton, FL
License number
Florida ME59132
Category
Osteopathic Medicine
Type
Cardiovascular Disease
Address
Address
7900 Glades Rd SUITE 400, Boca Raton, FL 33434
Phone
(561) 488-5535
(561) 488-2150 (Fax)
(561) 488-2150 (Fax)
Personal information
See more information about SETH J. BAUM at radaris.comName
Address
Phone
8346 Stagecoach Ln, Boca Raton, FL 33496
2300 Glades Rd #305E, Boca Raton, FL 33431
901 Meadows Rd, Boca Raton, FL 33486
8346 Stagecoach Ln, Boca Raton, FL 33496
6178 31St Ave, Boca Raton, FL 33496
Professional information
Dr. Seth J Baum - MD (Doctor of Medicine)
Hospitals:
Seth Baum MD
7900 Glades Rd SUITE 400, Boca Raton 33434
Boca Raton Regional Hospital
800 Meadows Rd, Boca Raton 33486
Seth Baum MD
7900 Glades Rd SUITE 400, Boca Raton 33434
Boca Raton Regional Hospital
800 Meadows Rd, Boca Raton 33486
7900 Glades Rd SUITE 400, Boca Raton 33434
Boca Raton Regional Hospital
800 Meadows Rd, Boca Raton 33486
Seth Baum MD
7900 Glades Rd SUITE 400, Boca Raton 33434
Boca Raton Regional Hospital
800 Meadows Rd, Boca Raton 33486
Education:
Medical Schools
Columbia University College Of Physicians And Surgeons
Graduated: 1985
Columbia University College Of Physicians And Surgeons
Graduated: 1985
Seth J Baum, Boca Raton FL
Specialties:
Cardiologist
Address:
7900 Glades Rd, Boca Raton, FL 33434
Education:
Columbia University, College of Physicians and Surgeons - Doctor of Medicine
Bellevue Hospital Center - Residency - Family Medicine
Bellevue Hospital Center - Residency - Family Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Cardiovascular Disease (Internal Medicine)
Fatty Acid Compositions And Methods Of Use
US Patent:
2009001, Jan 8, 2009
Filed:
Jul 3, 2008
Appl. No.:
12/167569
Inventors:
Seth J. Baum - Boca Raton FL, US
International Classification:
A61K 9/48, A61K 31/201, A61K 36/53
US Classification:
424463, 514560, 424725
Abstract:
The invention relates to highly concentrated DHA and EPA formulations in a soft gel capsule. A capsule may contain at least 80% omega-3 fatty acids, salts or derivatives thereof, where EPA and DHA are present in relative amounts of greater than or equal to 3:1 or less than or equal to 1:3, and constitute at least 75% to greater than 95% of the total fatty acids present in the capsule. Capsules of the invention may be provided in a blister package so as to provide clean and protected oils that are easy to travel with. Compliance is improved with one-pill-a-day dosing and the days of the week imprinted on the foil packing. Anitoxidant protection may be provided by rosemary and vitamin C. The invention also provides a methods of treatment, modulation or prophalaxis of coronary disease, altering serum LDL-cholesterol and/or HDL-cholesterol, lowering serum triglycerides, lowering blood pressure, pulse rate, altering the activity of the blood coagulation factor VII complex, mild hypertension, protection from cyclosporine toxicity in kidney transplant, rheumatoid arthritis, development and progression of retinopathy, hypertriglyceridemia, and neurological disorders in a subject.
Compositions And Methods Of Treating Chronic Kidney Disease
US Patent:
2008031, Dec 25, 2008
Filed:
Jun 20, 2008
Appl. No.:
12/143022
Inventors:
Seth J. Baum - Boca Raton FL, US
International Classification:
A61K 9/48, A61K 38/16, A61K 38/43, A61K 33/34, A61P 21/00, A61P 13/12, A61K 31/375, A61K 31/714
US Classification:
424 941, 514 12, 514 52, 424463, 514474, 424638
Abstract:
The invention relates to nutritional compositions and methods of using these compositions for the treatment of renal disease. More particularly, the invention discloses compositions of vitamins, minerals, amino acids, and/or proteins in amounts that can be used to supplement the nutritional deficiencies observed in patients afflicted with renal disease, renal insufficiency, or end-stage renal disease. The compositions of the invention can also be used as nutritional supplements for patients undergoing dialysis therapy or for patients on a restricted diet. In addition, the compositions can be used in combination or alone as a method of treating or managing a subject in the various stages of chronic renal disease, or throughout disease progression.